This medication functions by inhibiting VEGF-A activity, thereby obstructing the formation of tumor blood vessels and effectively suppressing tumor growth.[1] Despite the pronounced therapeutic efficacy of Bev in clinical treatment, its side effects cannot be ignored. Here, VEGFA is linked to neoplasm.